** Shares in Compugroup COP1n.DE jump 6.6% after Berenberg
raises the German medical software company to "buy" from "hold"
and Morgan Stanley ups it to "equal weight" from "underweight"
** The brokers see good prospects in the company's Hospital
Information Systems (HIS) business, as its order book should
compensate for a likely shortfall in Austria
** Berenberg sees less pressure on employee costs and
moderating R&D expenses in 2024, saying more progress can be
made to grow margins
** "We expect a strong finish to 2023 in the HIS segment and
remain confident that CGM can meet the lower end of its guided
260 million - 300 million euros ($285 million-$329
million)adjusted EBITDA range," Berenberg says
** It says consolidation and decommissioning of some smaller
software solutions should further drive the margin
** MS says Compugroup is a "quality health tech software
company" with a large recurring revenue base trading at a
relatively fair valuation
** MS adds the Ambulatory Information Systems and Pharmacy
Information Systems businesses are relatively mature, with a lot
of digitalisation already done; sees better growth prospects in
the HIS and data businesses
** The stock is on track for its best day since October 2022
and sits on top of Germany's small-cap index .SDAXI
($1 = 0.9123 euros)
(Reporting by Ozan Ergenay)
((ozan.ergenay@thomsonreuters.com))